Clinical Trials
38 trialsPomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
National Institutes of Health Clinical Center (CC)
Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
National Institutes of Health Clinical Center (CC)
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Navidea Biopharmaceuticals
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
National Cancer Institute (NCI)
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
Fred Hutchinson Cancer Center
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
National Institutes of Health Clinical Center (CC)
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
National Cancer Institute (NCI)
Spectroscopy With Surface Coils and Decoupling
Memorial Sloan Kettering Cancer Center
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
AIDS Malignancy Consortium
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers
Washington University School of Medicine
Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
Roswell Park Cancer Institute
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Pfizer
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Case Comprehensive Cancer Center
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Case Comprehensive Cancer Center
Twins Study of Gene Therapy for HIV Infection
National Institutes of Health Clinical Center (CC)
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
NIH AIDS Clinical Trials Information Service
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4
NIH AIDS Clinical Trials Information Service
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
NIH AIDS Clinical Trials Information Service
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
NIH AIDS Clinical Trials Information Service
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
A Study of Tecogalan Sodium
NIH AIDS Clinical Trials Information Service